HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael W Decker Selected Research

pozanicline

4/2014ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease.
10/2007Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition.
1/2004ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael W Decker Research Topics

Disease

9Pain (Aches)
10/2011 - 01/2004
8Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
10/2007 - 04/2002
7Schizophrenia (Dementia Praecox)
04/2007 - 04/2002
6Neuralgia (Stump Neuralgia)
10/2011 - 12/2004
6Hyperalgesia
10/2011 - 12/2004
5Alzheimer Disease (Alzheimer's Disease)
12/2015 - 04/2002
4Parkinson Disease (Parkinson's Disease)
12/2015 - 04/2014
4Postoperative Pain
10/2011 - 03/2005
3Dyskinesias (Dyskinesia)
12/2015 - 04/2014
3Cognitive Dysfunction
04/2007 - 01/2004
3Seizures (Absence Seizure)
09/2005 - 01/2004
2Parkinsonian Disorders (Parkinsonism)
12/2015 - 10/2014
2Nausea
03/2011 - 10/2007
2Vomiting
03/2011 - 10/2007
2Hypothermia
10/2004 - 01/2004
2Nervous System Diseases (Neurological Disorders)
08/2004 - 06/2003
1Amyloid Plaque
02/2014
1Brain Diseases (Brain Disorder)
03/2011
1Inflammation (Inflammations)
02/2010
1Osteoarthritis
06/2009
1Mood Disorders (Mood Disorder)
03/2009
1Mental Disorders (Mental Disorder)
09/2007
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2007
1Hyperthermia
08/2006
1Body Weight (Weight, Body)
08/2006
1Central Nervous System Diseases (CNS Diseases)
07/2006
1Erectile Dysfunction
04/2006
1Acute Pain
02/2006
1Epilepsy (Aura)
09/2005
1Neural Tube Defects (Exencephaly)
09/2005
1Catalepsy
05/2005
1Edema (Dropsy)
12/2004
1Hypersensitivity (Allergy)
12/2004
1Narcolepsy
08/2004

Drug/Important Bio-Agent (IBA)

8Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
12/2015 - 01/2004
6NicotineFDA Link
12/2015 - 01/2004
6Analgesics (Analgesic Drugs)IBA
10/2011 - 01/2004
5Histamine H3 Receptors (Histamine H3 Receptor)IBA
10/2010 - 06/2003
4Pharmaceutical PreparationsIBA
12/2015 - 05/2005
4CarrageenanIBA
10/2011 - 12/2004
3Levodopa (L Dopa)FDA LinkGeneric
12/2015 - 04/2014
35- (6- (1- azabicyclo(2,2,2)oct- 3- yloxy)pyridazin- 3- yl)- 1H- indoleIBA
12/2015 - 09/2010
3pozaniclineIBA
04/2014 - 01/2004
3Freund's AdjuvantIBA
02/2010 - 12/2004
3ciproxifanIBA
04/2007 - 05/2005
3Histamine (Histamine Dihydrochloride)FDA Link
04/2007 - 04/2002
3Methylphenidate (Ritalin)FDA LinkGeneric
08/2006 - 04/2002
23- (5,6- dichloropyridin- 3- yl)- 3,6- diazabicyclo(3.2.0)heptaneIBA
12/2015 - 04/2014
25-(2-azetidinylmethoxy)-2-chloropyridineIBA
10/2011 - 02/2005
2Formaldehyde (Formol)FDA Link
10/2010 - 12/2004
2alpha7 Nicotinic Acetylcholine ReceptorIBA
09/2010 - 09/2007
2Scopolamine (Hyoscine)FDA Link
02/2010 - 01/2007
23- methyl- 5- (1- methyl- 2- pyrrolidinyl)isoxazoleIBA
10/2007 - 04/2002
2imidazoleIBA
08/2006 - 05/2005
2Dopamine D4 Receptors (Dopamine D4 Receptor)IBA
04/2006 - 09/2005
24- (2- (2- ((2r)- 2- methyl- 1- pyrrolidinyl)ethyl)- 5- benzofuranyl)- benzonitrile (ABT 239)IBA
05/2005 - 04/2005
2Vincristine (Oncovin)FDA LinkGeneric
02/2005 - 12/2004
1ABT-126IBA
12/2015
1Carbidopa (Lodosyn)FDA LinkGeneric
12/2015
1A-582941IBA
02/2014
1Acetates (Acetic Acid Esters)FDA Link
10/2011
13- (3- (pyridine- 3- yl)- 1,2,4- oxadiazol- 5- yl)benzonitrileIBA
10/2011
1Acetylcholine (Acetylcholine Chloride)FDA Link
03/2011
16- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 3- pyridinecarboxamideIBA
10/2010
1Diclofenac (SR 38)FDA LinkGeneric
02/2010
1Duloxetine Hydrochloride (Cymbalta)FDA Link
02/2010
1Celecoxib (Celebrex)FDA Link
02/2010
1Fluoxetine (Prozac)FDA LinkGeneric
02/2010
1CytokinesIBA
03/2009
1Cholinergic Agents (Cholinergics)IBA
10/2007
1Dopamine (Intropin)FDA LinkGeneric
10/2007
1Norepinephrine (Noradrenaline)FDA LinkGeneric
10/2007
1Dizocilpine Maleate (Dizocilpine)IBA
01/2007
1LigandsIBA
08/2006
14- ((3- (4- (2- aminopropanoyl)- 1- piperazinyl)propoxy)phenyl)cyclopropylmethanoneIBA
08/2006
1Interleukin-1 (Interleukin 1)IBA
02/2006
1Naloxone (Narcan)FDA LinkGeneric
02/2006
1Morphine (MS Contin)FDA LinkGeneric
02/2006
1Pentylenetetrazole (Metrazol)IBA
09/2005
12-(3',4',5',6'-tetrahydro-2'H-(2,4') bipyridinyl-1'-yl)-N-m-tolyl-acetamideIBA
09/2005
1ABT-769IBA
09/2005
1N- ((4- (2- cyanophenyl)- 1- piperazinyl)methyl)- 3- methylbenzamideIBA
09/2005
1Fatty Acids (Saturated Fatty Acids)IBA
09/2005
1thioperamideIBA
05/2005
1Haloperidol (Haldol)FDA LinkGeneric
05/2005
1Antipsychotic Agents (Antipsychotics)IBA
05/2005
1Risperidone (Risperdal Consta)FDA LinkGeneric
05/2005
1Ketoconazole (Nizoral)FDA LinkGeneric
05/2005
1benzofuranIBA
04/2005
1benzonitrileIBA
04/2005
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
03/2005
1Cholinergic AgonistsIBA
02/2005
1Glutamic Acid (Glutamate)FDA Link
12/2004
1Acetic Acid (Vinegar)FDA LinkGeneric
12/2004
1epibatidineIBA
10/2004
1Histamine H3 AntagonistsIBA
08/2004

Therapy/Procedure

4Therapeutics
10/2014 - 05/2005
3Ligation
10/2010 - 12/2004
1Drug Therapy (Chemotherapy)
02/2005
1Pain Management
12/2004